Dermatologica Sinica

: 2022  |  Volume : 40  |  Issue : 1  |  Page : 1--2

Aiming at a bright future

Ching-Chi Chi 
 Department of Dermatology, Chang Gung Memorial Hospital, Linkou; School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan

Correspondence Address:
Prof. Ching-Chi Chi
Department of Dermatology, Chang Gung Memorial Hospital, Linkou, 5, Fuxing St, Guishan Dist, Taoyuan

How to cite this article:
Chi CC. Aiming at a bright future.Dermatol Sin 2022;40:1-2

How to cite this URL:
Chi CC. Aiming at a bright future. Dermatol Sin [serial online] 2022 [cited 2023 May 29 ];40:1-2
Available from:

Full Text

First launched as an official journal of the Taiwanese Dermatological Association (TDA) in 1983, the Dermatologica Sinica has become an international journal indexed by bibliographic databases, including the Science Citation Index Expanded, Embase, and SCOPUS, based on the efforts of previous editors and reviewers. Starting this year, we have introduced 3-year fixed-term appointment for editors (corresponding to the term of Presidency of TDA). We have reorganized the Editorial Board to ensure at least one-third of editors from international academia and have introduced Statistics Editors to provide statistical support. Further, we have introduced Social Media Editors and set up web pages on Facebook, Instagram, and Twitter [Table 1] to disseminate research findings and promote their application in clinical practice. Hopefully, the Dermatologica Sinica will make a greater impact on clinical and academic dermatology in the future.{Table 1}

 This Issue of Dermatologica Sinica

Thread lifting has been widely adopted for its minimally invasive nature. The esthetic effects depend on the proper placement of threads in the optimal anatomic locations. To improve the efficacy and safety of thread lifting, Wang et al. presented novel real-time imaging techniques with transillumination, ultrasound, and Doppler for three-dimensional guidance and confirmation.[1]

With the persistent pandemic of COVID-19, dermatologists have witnessed various cutaneous manifestations of the disease itself and adverse events associated with vaccinations.[2],[3] “Moderna arm” is a well-known delayed localized hypersensitivity reaction to mRNA vaccines. Hung et al. reported a delayed cutaneous reaction caused by ChAdOx1 nCoV-19 (AZD1222) vaccine presenting as “AZ arm.”[4] On the other hand, Lin and Chi reported a case of erythrodermic psoriasis following ChAdOx1 nCOV-19 vaccination.[5] Therefore, dermatologists can contribute to the fight against COVID-19 though in an indirect way.

Previous studies on the persistence of biological therapies for psoriatic disease focused on psoriasis. Yu et al. used a hospital-based research database to perform an analysis on the drug survival of biological agents in patients with psoriatic arthritis.[6] They found a higher drug survival of ustekinumab than adalimumab in a Taiwanese population, suggesting that ethnic differences may exist in genetic and environmental factors yet to be identified.

Financial support and sponsorship


Conflicts of interest

There are no conflicts of interest.


1Wang YH, Yang CS, Chang KC, Chang SL, Cheng CY, Huang YL. The applications of real-time imaging with transillumination, ultrasound, and Doppler for thread lifting. Dermatol Sin 2022;40:44-7.
2Wei KC, Yang CC. Hair loss and COVID-19. Dermatol Sin 2021;39:167-8.
3Ma SH, Sytwu HP, Chen CC. The cutaneous manifestations related to COVID-19 infection and vaccination: Current aspects and future prospects. Dermatol Sin 2021;39:65-6.
4Hung WK, Chi CC, Wang SH. AZ arm: Delayed cutaneous reaction to ChAdOx1 nCoV-19 (AZD1222) vaccine. Dermatol Sin 2022;40:52-3.
5Lin PT, Chi CC. Erythrodermic psoriasis following ChAdOx1 nCOV-19 vaccination: A case report. Dermatol Sin 2022;40:62-3.
6Yu S, Tsao YH, Tu HP, Lan CC. Drug survival of biologic agents in patients with psoriatic arthritis from a medical center in southern Taiwan. Dermatol Sin 2022;40:20-7.